Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK058110)
American Heart Association (16POST27250118)
Received: 22 September 2020
Accepted: 4 June 2021
First Online: 24 June 2021
: W.L.K. is a founder, consultant, and SAB member for Ribon Therapeutics, Inc. and ARase Therapeutics, Inc. He is also coholder of U.S. Patent 9,599,606 covering the ADP-ribose detection reagent used herein, which has been licensed to and is sold by EMD Millipore. The other authors declare no competing interests.